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ABSTRACT
Solid pseudo-papillary tumor (SPPT) is a rare cystic tumor of
the pancreas (1-3% of exocrine tumors of the pancreas) which
shows an “enigmatic” behavior on the clinical and molecular pat-
tern. A retrospective analysis of the citological studies and resect-
ed specimens of pancreatic cystic tumors from May 1996 to Feb-
ruary 2010 was carried out. Three cases of SPPT were found,
which are the objective of this study. The diagnosis was estab-
lished upon occasional finding in the abdominal CT, in spite of siz-
ing between 3 and 6 cm of diameter. In the three cases the pre-
operative diagnosis was confirmed by citology and specific
immunohistochemical staining. Cases 2 and 3 showed strong im-
munoreactivity for Beta-Catenina and E-Cadherina staining. Radi-
cal resection (R0) was carried out in the three cases. A young
male –21 years of age (case 1)- who had duodenal infiltration and
two lymph nodes metastases died of hepatic and peritoneal recur-
rence 20 months following surgery. The other two cases are free
of disease. The current review of the literature reports roughly
800 cases since the first report in 1959, and shows the enigmatic
character of this tumor regarding the cellular origin, molecular
pathways, prognostic factors and clinical behavior.
Key words: Solid-pseudopapillary tumor. Pancreatic cystic neo-
plasm. Prognosis. Beta-catenina.
RESUMEN
El tumor pseudopapilar (TSPP) es un tumor quístico del pán-
creas muy poco frecuente (1-3% de los tumores exocrinos del
páncreas) y que tiene un comportamiento oncológico y molecular
“enigmático”. Se realizó un análisis retrospectivo de las citologías
de las lesiones quísticas del páncreas, así como de los tumores
quísticos resecados entre mayo de 1996 y febrero de 2010, en-
contrándose tres tumores SSPP, motivo de este estudio. En los
tres casos el diagnóstico fue ocasional en el TC abdominal a pesar
de presentar unos tamaños entre 3 y 6 cm de diámetro. En los
tres casos se confirmó el diagnóstico preoperatorio mediante cito-
logía e inmunohistoquímica. En los casos 2 y 3 se confirmó la po-
sitividad para Beta-Catenina y E-Cadherina. En todos los casos se
realizó cirugía radical (R0). Un varón de 21 años –caso 1- que pre-
sentaba infiltración duodenal y metástasis ganglionares falleció de
progresión hepática y peritoneal a los veinte meses de la cirugía.
Las otras dos pacientes –casos 2 y 3- se encuentran libres de reci-
diva. La revisión de la literatura desde su descripción en 1959
hasta la actualidad –aproximadamente 800 casos- confirma el ca-
rácter enigmático de este tumor en relación a su origen celular,
molecular, factores pronósticos y comportamiento clínico.
Palabras clave: Tumor sólido-pseudopapilar, Tumores quísti-
cos de páncreas. Pronóstico.
INTRODUCTION
The solid pseudopapillary tumor (SPPT) of the pan-
creas was first described by Franz in 1959 and character-
ized by Hamoudi in 1970, resulted in either “Franz” or
“Hamoudi” tumors (1,2). It is an uncommon pancreatic
cystic tumor (1-3% of exocrine pancreas neoplasms)
which shows an enigmatic pattern from oncological and
molecular perspectives. Long-term survival superior to
10-12 years have been reported in spite of vascular inva-
sion and peritoneal or hepatic involvement (3-5). The
SPPT usually has a benign evolution affecting young fe-
males (2nd-3rd decade), having related with sex hormones
etiology although this hypothesis has not been confirmed.
Some authors have reported a more aggressive evolution
in young males (6-8).
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CLINICAL NOTE
Its biological and clinical pattern differs from the rest
of the cystic neoplasms of the pancreas, which have
aroused a great interest in the last decade (9-11). Since
1933, 718 cases have been described until 2005 and cur-
rently around 800 cases have been reported (10-17).
We present three cases of SPPT with different clinical
features and outcomes, which confirm the “enigmatic”
characteristics of this tumor which has been occasion of
an editorial in this journal in 2006 (9).
PATIENTS AND METHODS
Between October 1996 and February 2010, 118 cyto-
logic al studies of cystic lesions of the pancreas were per-
formed in our Institution. Most of them were obtained by
fine-needle aspiration (FNA) during computerized to-
mography (CT) or upper endoscopic ultrasound (EUS)
procedure. In October 2006 the brush cytology technique
was introduced (Echobrus Cook Medical, Winston-
Salem, North Carolina, USA). A retrospective analysis of
the clinical, surgical and cytopathological parameters of
the cystic tumors diagnosed according with the 1996
World Health Organization (WHO) guidelines and re-
viewed in 2000 was performed (18,19). Three cases of
SPPT were diagnosed in that period.
Case 1. A 17 year-old male with previous history of
duodenal ulcer, presented a great ulcer and deformation
of duodenal wall in a routine endoscopy. An abdominal
CT and magnetic resonance imaging (MRI) showed a
great solid-cystic lesion in the head of the pancreas. The
FNA cytology reported an “epithelial malignant tumor”.
The patient was referred to our Center. On admission, the
blood analysis showed: Hb. 9.3 g/dL; Hto. 27.5%; Iron:
11 µg/mL. Total Bilirubin: 4.54 mg/dL; Gastrin 101
pg/mL (normal values < 150 pg/mL) and CA-19.9: 11.3
U/mL.
In the abdominal CT a 6 cm diameter tumor in the
head of the pancreas was assessed, with compression on
the duodenal wall and impingement of the mesenteric
vein and celiac axis as well. The FNA cytology was in-
formed as “solid-pseudopapilar neoplasm” with
pseudopapillary pattern.
The patient underwent a total pancreatectomy due to
global involvement of the pancreatic gland by a solid-
cystic tumor without infiltration of the mesenteric ves-
sels. The patient was reoperated at the 11th postoperative
day for a gastrojejunal dehiscence and was discharged on
the 20th postoperative day. The gross description reported
a solid mass of 6.5 cm diameter which involved whole
gland with intraluminal invasion and multiple hemor-
rhagic cystic structures. The microscopic study described
a neoformation with papillary pattern alternating with
microcystic areas. The tumor invaded the duodenal wall
with negative surgical margins. Two of the lymph nodes
were infiltrated. The patient was treated with adjuvant ra-
diotherapy (51 Gy) and chemotherapy (Cysplatin, 5-FU)
and later on with Docetaxel and Gemcytabin (20). 14
months after operation a loco-regional recurrence and
liver metastases were observed dying 20 months after
surgical resection.
Case 2. An incidental 6 x 6.5 cm diameter cystic lesion
located in the tail of the pancreas was discovered in
asymptomatic 28 year-old female. The EUS confirmed
the expansive pattern. The cytopathological study de-
scribed several branch of papillary fronds, consisting of a
central fibrovascular stalk covered with several lawyers
of neoplastic cells compatible with SPPT. The patient un-
derwent laparoscopic distal pancreatectomy without inci-
dences and remains free of recurrence and symptoms 4
years after operation. The gross appearance revealed a
well circumscribed solid-cystic lesion of 6.5 cm diame-
ter, with multiple hemorrhagic and necrotic areas (Fig. 1-
A). The microscopic study revealed an epithelioid neo-
plasic alternating solid pattern with cystic spaces and
pseudopapillae formed by connective tissue stalks which
delineated clusters of epitheloid cells. The surgical mar-
gins and lymph nodes were negative (Fig. 1-B).
The immunohistochemical study was positive for Vi-
mentin, α1-antitrypsin (AAT), CD-10 and CD-56; and
negative for cytokeratin-7, cytokeratin-19, synaptophysin
and chromogranin A.
Case 3. A 24 year-old female who consults for a sec-
ond opinion with the previous diagnosed of pancreatic
cystoadenoma. She was diagnosed 8 years before with
occasion of an incidental finding in an abdominal CT
when the lesion measured 3 cm diameter size.
In posterior controls she remained asymptomatic al-
though an increase of the lesion up to 4.5 cm diameter
and portal vein compression was assessed when she de-
cided to consult in our Department (Fig. 2).
The SPPT diagnosis was confirmed by EUS and FNA
cytology. The immunohistochemical staining was posi-
tive for nuclear beta-catenin and cytoplasmatic CD-10
(Fig. 3). The patient underwent Whipple procedure and
discharged on 5 postoperative day with regular diet. The
gross study described a well circumscribed solid lesion of
3.5 x 3.5 x 4.5 cm size in the head of the pancreas which
displaced the pancreatic parenchyma and obstructing the
Wirsung duct (Fig. 4). In the microscopic study, an ep-
ithelioid neoplasia growing in cellular clusters delineated
by connective tissue stalks with pseudopapillary struc-
tures.
The tumor was well circumscribed by a fibrous tissue
band with surgical margins free of disease and negative
nodes. The immunohistochemical study was positive for
CD-10, nuclear and cytoplasmatic Beta-Catenin and for
progesterone receptors (85%).
DISCUSSION
The SPPT was first described by Franz in 1959 and
posteriously characterized by Hamoudi in 1970 (1, 2).
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The tumor was denominated solid-pseudopapillary with
occasion of the exocrine pancreas classification in 1996
(18). It is a rare tumor (1-3% of the exocrine neoplasms)
which predominantly affects to young females between
20-30 years of age, and with an overall 5 years survival
rate of 95-98% and 10 year of 93% respectively after
surgery (12,22).
From the biological, molecular and oncological point
of view, it represents and “enigmatic” tumor from which
the origin, prognostic factors and natural history are un-
known, having aroused a great interest and awareness in
the last decades, when several clinical series and excel-
lent reviews have been reported (4,8-11,13,15-17,22-26).
From the three presented cases, highlights the first
one, the case of a 17 year-old boy whenever the preva-
lence in males is between 3.9% and 6.6% (12,22).
Machado and cols. reported the tumor in 7 males in a
case series of 34 patients. This author reported a more ag-
gressive histological pattern in the males although not de-
finitive prognostic factors were obtained due to the limit-
ed number of patients (8). Other authors have reported
bigger and more solid tumors in males without differ-
ences in survival (6,7). Table I summarizes the anatomi-
cal and clinical features of the largest series.
In the previous mentioned patient, the clinical presen-
tation and evolution after radical surgery (R0) was very
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Fig. 1. A. Gross appearance of distal pancreatectomy specimen by SPPT (case 2) showing the solid and cystic component with hemorrhagic areas. B.
Microscopic examination showing pseudopapillae (H & E x 400).
Fig. 2. Radiological imaging of case 3 on unenhanced CT and MR. A. A large well-encapsulated mass affecting the duodenum and portal vein. B. MR
image reveals peripheral enhancement.
unusual developing early loco-regional recurrence and
distant development of metastases in spite of adjuvant
treatment, dying on the 16 postoperative month. We have
found ten cases of a total of 433 published patients
(2,3%) in 17 clinical series with a similar evolution (4,6-
8,11,14,16,23-32). Tang et al., from Memorial Sloan-Ket-
tering, published two similar cases out of 36 patient se-
ries, who died at 6 and 16 months after surgical resection.
They were two females of superior age to the mean (33
and 45 years) who had large tumors of 9 and 20 cm diam-
eter size respectively. One case showed a synchronic liv-
er metastases and the other one lymph node involvement.
Tumor necrosis, diffuse invasion, a higher mitotic index
and infiltration with invasion of the duodenal lumen, as
well as in our case number 1, were the differential find-
ings (11, 33) with the remaining 34 patients.
One of the paradigmatic fact of SPPT is that long-term
survival –superior to 5 – 12 years- have been assessed in
the setting of patients with liver metastases, multiple
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Fig. 3. Fine-needle aspirate from a patient with SPPT (case 3). A. Demonstrates fibrovascular stalks with cells lined at the surface an periphery of the
core (Romanowsky stain x 200). B. Demonstrates ovoid cells lining the fibrovascular core with finely granular chromatin pattern (Romanowsky stain x
400). C. Detail showing the nuclear pattern with intense labeling for β-Catenin (x 400). D. Demonstrates positive staining with immunoperidoxidase
for CD-10 (x 400) from the same case.
Fig. 4. Gross appearance of pancreatoduodenectomy specimen for
SPPT (case 3) showing the well circumscribed solid lesion in the head of
the pancreas, displacing the rest of the parenchyma.
node metastases and incomplete resections as well
(10,12,14,16).
In our cases, the diagnosis was established as incident
al lesion on CT imaging in spite of being large tumors
with an axial diameter between 4.5 and 8 cm. When pre-
senting, the abdominal symptoms are vague and unspe-
cific (epigastric discomfort, nausea, weight loss). Only
1% of the patients present jaundice, even with tumors lo-
cated in the head of the pancreas, as occurred in cases 1
and 3 (10,12,16,17,22).
The radiological features on CT and MRI show well
circumscribed lesions with solid cystic changes and the
presence of hemorrhagic areas within the tumor with
high signal intensity on T1-weighted images after
gadolinium –enhanced pulse sequences- (34). The three
cases were preoperatively diagnosed with the FNA cytol-
ogy study. This method, which is the most accurate for
the cystic neoplasms of the pancreas, has been unusually
described by most of the authors. In a review of 718 pa-
tients, only 52 cases (7%) were diagnosed by the FNA
(12). Salvia et al. performed this technique in only 10 pa-
tients out of 31 (32.2%) SPPT’s patients with a sensitivity
of 50% (14).
Jani reports a 75% efficacy (21/28 cases) with FNA
guided in EUS exploration and points out the value of the
immunohistochemical study in the cytology (35,36).
From the cytological view the different diagnosis with
neuroendocrine tumors (NET) it could be difficult, whereas
a positive staining for chromogranine A, CD10, PR and
CD56 have been described in both tumors (11,37-39).
The nuclear and cytoplasmic expression of E-Cad-
herin and beta-caterin members of the Wnt pathway as
specific markers have been reported in the 100% of
TSP meanwhile on the NET the beta-catenin expression
is located in the cellular membrane (24,40-42). These
techniques should be incorporated in the diagnostic ar-
mamentarium when SPPT would be suspected (43). In
our most recent case –number 3- the nuclear im-
munoreactivity for Beta-Catenin confirmed the diagno-
sis.
The origin of the SPPT is still an enigma. The origi-
nal cell of the tumor has not been identified in spite of
the recent immunohistochemical findings (44). Some
authors have proposed the ovaric origin due to the rela-
tion of the pancreas with the genital ridge during the
early embryogenesis (44). Geers has recently suggested
the pancreatic acinar cells as its origin, although the de-
bate regarding the SPPT ontogenesis is continuing
(9,40,41,45,46).
The prognostic factor neither have been identified,
having related the outcomes with the tumor size, mitot-
ic index, necrosis grade, duodenal invasion and the
presence of lymphatic metastases (8, 11, 16, 47). This
enigmatic pattern contrasts with the recent knowledge
of the cystic tumor of the pancreas as the intraductal
papillary mucinous neoplasm (IPMN) (48, 49, 50).
Finally we mention the alteration on β-Catenin / E-
Cadherin. The β-Catenin protein is involved in the de-
velopment and organogenesis of multiple tissues regu-
lated by the Wnt/β-Catenin signalization pathway.
Recent studies have pointed out the role of this path-
way in the pancreas organogenesis being inhibited in
the adult pancreas tissue (51, 52). β-Catenin/APC mu-
tations and Wnt signaling pathway alterations have
been associated with the pancreatoblastoma, acinar car-
cinoma, pancreatic ductal adenocarcinoma and SPPT
(40,41,53-55).
Heiser et al has recently developed an experimental
model in mice, inducing the mutation in that pathway,
suggestion that these alterations would be the origin of
SPPT (46). In spite of these findings the SPPT is an
“enigmatic” tumor with aspects remaining to be revealed.
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Table I. Clinical experience in SPPT*. Most numerous series in adults
Author (Ref.) Year Age No. cases Sex ratio Symptoms Size Surgical procedure Follow-up Results
(M/F) n (%) (cm) DPC PD PC PT Enuc. Other (m)
Sun (23) 2003 27 (11-59) 28 23/5 23 (82%) 6 (1,2-6) 10 16 2 67 (7-110) 28 alives
1 liver recurrence
Papavramidis* (12) 2005 22 (2-89) 710 626/84 6.08 (0.5-34) 142 221 7 5 26 150 * — 95% alive at 5 y.
Timptom (27) 2006 30 (15-57) 14 13/1 nc 7 (4-16) 3 10 1 87.6 (3-240) 12 alive
2 liver rec. at 7 & 1 y.
1 periton. Rec. at 14 m.
Salvia (14) 2007 31 (7-56) 31 27/4 14 (45%) 6 (2-15) 9 11 6 1 4 58.2 (7-229) 34 alive
No recurrence
Lee (4) 2008 30 (18-63) 62 57/5 21 (33%) 6 (1.5-14) 19 38 2 1 2 47.5 (5-240) 62 alive
2 rec. at 16 m. & 7 y.
Machado (8) 2008 23 (10-72) 34 27/7 27 (79%) 7 (1.5-15) 11 15 5 - 3
Reddy (16) 2009 32 (13-75) 37 33/4 27 (87%) 4.6 (0.3-12) 14 20 1 1 1 57.6 (0.8-328.8) 34 alive
1 rec. at 7.7 y.
*Review. DPC: Pancreaticoduodenectomy. DP: Distal pancreatectomy. CP: Central pancreatectomy. TP: Total pancreatectomy. Enuc.: Enucleation
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